Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Regular ✕Franklin Asian Equity Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundFranklin Asian Equity Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCFranklin
NAV₹22.8170₹40.9618
NAV date20 Nov 202619 Nov 2026
History3.1 years18.8 years
Expense ratio2.1%2.5%
Stars★★★★★★★★★★
Growth Score93.9068.10

Returns

HDFC Pharma and Healthcare FundFranklin Asian Equity Fund
1 month+12.87%−1.89%
3 months+6.85%−8.92%
6 months+17.20%−4.16%
YTD+32.43%+15.22%
1 year+30.73%+19.83%
3 years (CAGR)+29.16%+18.38%
5 years (CAGR)—+5.85%
10 years (CAGR)—+9.48%
Since launch+30.28%+8.06%

Risk

HDFC Pharma and Healthcare FundFranklin Asian Equity Fund
Volatility15.8%17.7%
Downside volatility8.6%10.5%
Sharpe1.440.67
Sortino2.641.13
Calmar1.941.26
Return / risk1.851.04
Deepest fall−15.07%−42.78%
Days to recover133325
Below its high+0.00%−12.09%

Against benchmark

HDFC Pharma and Healthcare FundFranklin Asian Equity Fund
Alpha+6.36%+9.67%
Beta0.970.51
R²85.0%21.3%
Up capture106.7%67.6%
Down capture74.4%3.8%
Tracking error6.1%17.6%
Information ratio0.970.40
Treynor0.220.24

Consistency

HDFC Pharma and Healthcare FundFranklin Asian Equity Fund
Best 1-year+64.96%+73.08%
Middle 1-year+21.84%+10.69%
Worst 1-year+0.52%−34.42%
1-year periods with a loss0.0%24.7%
Middle 3-year+28.68%+9.00%
Positive months69.4%58.3%
Best day+3.19%+5.04%
Worst day−3.62%−6.67%
Worst 5% day−1.50%−1.68%
Positive days58.1%56.7%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundFranklin Asian Equity Fund
5-year XIRR—+14.07%
5-year value—₹8,59,386
3-year XIRR+26.26%+18.67%
1-year XIRR+39.84%+3.73%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth